Researchers crack code of German E. Coli outbreak

July 27, 2011

A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacterium that caused the ongoing deadly outbreak in Germany that began in May 2011. To date, 53 people have died in the outbreak that has sickened thousand in Germany, Sweden and the U.S. The paper, published July 27 in the New England Journal of Medicine (NEJM), describes how researchers around the globe worked together to use cutting edge technology to sequence and analyze the genomics of E. coli samples from the outbreak as well as closely related strains in a matter of days. They combined those findings with their knowledge of the biology and evolution of the bacteria to learn more about the outbreak. The analysis occurred rapidly enough to inform the physicians treating people who were infected, and assisted epidemiologists as they raced to trace the source of the pathogen.

The research may be the first time that such a comprehensive scientific analysis of an emerging pathogen took place in the first days and weeks of an , according to the study's lead author, David A. Rasko, Ph.D., assistant professor of microbiology and immunology at the University of Maryland School of Medicine, and a research scientist at the Institute for Genome Sciences.

"This technology is evolving extremely rapidly, enabling us to accomplish much more with unprecedented speed," says Dr. Rasko. "It took years and millions of dollars to sequence the first E. coli genome more than a decade ago. Here we are, just months from the start of the German E. coli outbreak, and we've published a paper on it. This paper and the research it describes represent the new paradigm of outbreak investigations."

The researchers collaborated with Pacific Biosciences of California, Inc., a Menlo Park-based company that used its new Single Molecule Real Time technology to sequence the genome of the E. coli strain from the German outbreak. The collaboration also included scientists from the Statens Serum Institute, the World Health Organization Collaborating Centre for Reference and Research on Escherichia coli and Klebsiella in Denmark, as well as Harvard and the University of Virginia.

"The University of Maryland School of Medicine has a global presence spanning 23 countries, and we are proud that our Institute for Genome Sciences has played a leading role in investigating this international health crisis and improving human health worldwide," says E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs of the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and dean of the School of Medicine.

Dr. Rasko and colleagues at the Institute for Genome Sciences analyzed the genomic data using computational tools, some of which were developed at the Institute. The Institute for Genome Sciences team included postdoctoral researchers Jason Sahl, Ph.D., and Susan Steyert, Ph.D., and lab manager Julia Redmond. Dr. Rasko's expertise is in the molecular pathogenesis and evolution of E. coli, which helped his team to interpret the massive amount of genomic data involved and learn more about the microbe and how it fits into the overall picture of E. coli.

Scientists found that the genome of the German outbreak E. coli strain was mostly enteroaggregative E. coli, a subtype of the bacteria. In carefully examining its genome, they found that the outbreak strain was actually an unusual combination of enteroaggregative E. coli and another subtype, known as enterohemmorhagic E. coli. Researchers also noted that the strain carried a unique set of virulence and antibiotic resistant factors, making it distinct from other strains of the bacteria.

"This is not just a genome paper. It also examines the virulence and biology of the microbe," says Dr. Rasko. "Early in the outbreak, scientists described bacteria as a 'hybrid' strain. This strain is not a true hybrid, because it contains only a small amount of DNA sequence from enterohemmorhagic E. coli. We have not seen these kinds of unique combinations very often in the past. I expect we are going to see them increasingly, now that technology like Pacific Biosciences' has advanced to the point that we can sequence more strains very rapidly and relatively inexpensively."

"The combination of speed, accuracy and cost will lead genomic sequencing to be a diagnostic tool quicker than anyone currently envisages," says Dr. Sahl, the paper's co-author.

When the outbreak began in May, scientists around the world began examining the E. coli strain as soon as samples were available. Many groups were releasing their findings to the public for free — the data in the current study are also publicly available — which resulted in a type of "crowd-sourcing," That is, research was being conducted through the collaboration of a large, disparate group around the globe. "Usually, science takes place in relative isolation," says Dr. Rasko. "This is the first time we've seen true 'open source' analysis of a microbial genome."

Very early on in the outbreak, German scientists used another sequencing technology and preliminary analysis to determine was unique about the pathogen associated with the outbreak. In fact, they identified a gene that produced a toxin associated with the very symptoms doctors saw in patients, such as severe diarrhea. This gene, known as the Shiga toxin, is produced more when certain antibiotics are used. The findings meant that patients' symptoms would worsen when they were treated with antibiotics. Those initial findings immediately began to inform clinical care, as doctors stopped using antibiotics to treat infected patients. "Our research is a more detailed, comprehensive analysis than that early research," says Dr. Rasko. "This was an international collaboration pulled together in a matter of days. I expect we will see more collaborations like this to deal with new emerging pathogens in the future."

The NEJM paper will provide new, detailed information to assist researchers and physicians as they continue to investigate the ongoing E. coli outbreak in Europe.

"It's exciting to be at the forefront of genomics like this," says Dr. Rasko. "This research was a chance for us to leverage the power of the Institute for to help create a new paradigm for the study of microbes and outbreaks. It also has implications for genomics as a tool in routine diagnostics."

Explore further: EHEC 2011 outbreak: Scientists publish their prospective genomic characterization

Related Stories

EHEC 2011 outbreak: Scientists publish their prospective genomic characterization

July 20, 2011
Scientists of the Medical Faculty of the University Munster and the University Hospital Munster in collaboration with scientists of the enterprise 'Life Technologies Corporation' were the first to release a draft genome sequence ...

BGI sequences genome of the deadly E. coli in Germany and reveals new super-toxic strain

June 2, 2011
The recent outbreak of an E. coli infection in Germany has resulted in serious concerns about the potential appearance of a new deadly strain of bacteria. In response to this situation, and immediately after the reports of ...

French woman dies of E. coli

July 2, 2011
(AP) -- A 78-year-old French woman died early Saturday morning from complications of E. coli infection but a doctor said she was not suffering from the strain that has infected many other people in France and Germany.

Threat to United States from new European E. coli strain unclear

June 14, 2011
(Medical Xpress) -- Over the centuries, many unexpected things have come to the United States from Germany and caught on -- lager beer, sauerkraut, bratwurst and the Volkswagen Beetle are a few that come to mind -- but don't ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...


Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Jul 28, 2011
A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacterium that caused the ongoing deadly outbreak in Germany that began in May 2011.

It's not ongoing anymore.
Two days ago the German Robert Koch Institut has declared that the EHEC epidemic is over.
not rated yet Jul 28, 2011
Lots of information, but did scientists ever determine the source of this virulent E.coli? And was it a laboratory strain that got out, as some have charged? How did this bacteria become resistant to that many antibiotics without selective breeding?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.